Gilead Sciences Inc.
0
0
0%

Statistics

Valuation metrics
Market cap
137.01B
Enterprise value
153.38B
Trailing P/E (ttm)
17.07
Forward P/E
PEG ratio
Price/Sales (ttm)
4.70
Price/Book (mrq)
6.36
Enterprise Value/Revenue
5.27
Enterprise Value/EBITDA
10.85
Overview
Shares outstanding
1.24B
Float
1.24B
Shares short
% Held by insiders
0.10%
% Held by institutions
91.56%
Average volume (10 days)
2
Average volume (90 days)
1
Price summary
52-Week low
89.71
52-Week high
115.90
52-Week change
18.76
Beta
0.33
50-Day moving average
110.43
200-Day moving average
103.18
Dividends and splits
Forward annual dividend rate
3.16
Forward annual dividend yield
0.03
Trailing annual dividend rate
3.16
Trailing annual dividend yield
0.03
5-Year annual dividend yield
Payout ratio
0.49
Dividend date
Ex-dividend date
Dec 15, 2025
Last split factor
Last split date
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
27.88%
Operating margin
45.23%
Operational effectiveness
Return on assets
12.57%
Return on equity
40.71%
Income statement
Revenue (ttm)
29.09B
Revenue per share (ttm)
23.35
Quarterly revenue growth (yoy)
3%
Gross profit (ttm)
22.90B
EBITDA
14.26B
Net income to common (ttm)
8.11B
Diluted EPS (ttm)
6.46
Quarterly earnings growth (yoy)
143.60%
Balance sheet
Total cash (mrq)
8.49B
Total cash per share (mrq)
6.84
Total debt (mrq)
24.94B
Total Debt/Equity (mrq)
116.24
Current ratio (mrq)
145.30%
Book value per share (mrq)
17.34
Cash flow
Cash flow statement
9.67B
Levered free cash flow (LFCF)
8.03B
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 14 hours 48 minutes

18:41
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).